Premier Biosoft said this week that it has bought ProteoIQ, a proteomic data-analysis software suite, from Australian bioseparations company NuSep for an undisclosed sum.
NEW YORK (GenomeWeb News) – Premier Biosoft said on Monday it has completed the acquisition of NuSep's software business ProteoIQ for an undisclosed amount.
By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Australian bioseparations firm NuSep said on Monday it has extended the closing date of its current share purchase offer to Aug. 26.
The company will use funds from the offering to market its products, invest in a Singapore plasma project, and for general corporate purposes.
The suit, which also names Pierce Biotechnology and Expedeon as defendants, alleges they infringe on a patent related to a cassette for use in electrophoretic gels.
Agilent, Bruker, Biocius, IonSense, NuSep, New England Peptide
The separations products company plans to buy the mass spec analysis software maker for at least $3 million.
The deal, valued at more than $3 million, would provide NuSep with BioInquire's ProteoIQ software, which helps customers identify proteins separated by mass spec instruments.
Bloomberg reports that the DNA-for-cash deal reported in Kentucky might be a more widespread scam.
St. Jude Children's Research Hospital scientists have treated infants with X-linked severe combined immunodeficiency using gene therapy in an early phase study.
St. Louis Public Radio reports that some African Americans are turning to DNA ancestry testing to help guide genealogical searches.
In Nature this week: a genomic analysis of the snailfish Pseudoliparis swirei, ancient DNA analysis gives insight into the introduction of farming to England, and more.